Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$36.54 - $48.66 $380,016 - $506,063
10,400 New
10,400 $44,000
Q1 2022

May 12, 2022

SELL
$29.88 - $37.04 $501,984 - $622,272
-16,800 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$25.61 - $35.1 $430,248 - $589,680
16,800 New
16,800 $12,000
Q2 2018

Aug 13, 2018

SELL
$40.53 - $50.7 $579,579 - $725,010
-14,300 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$44.08 - $55.05 $70,528 - $88,080
1,600 Added 12.6%
14,300 $4,000
Q4 2017

Feb 09, 2018

BUY
$50.3 - $64.39 $638,810 - $817,753
12,700
12,700 $6,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.